BioXcel Therapeutics (BTAI) PT Lowered to $3.50 at UBS

March 13, 2024 8:08 AM EDT Send to a Friend

UBS analyst Colin Bristow lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioXcel Therapeutics (BTAI) PT Lowered to $3.50 at UBS

Member Login

Free News Feed